Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 831-838

  Anantharam, Arun ^a   Markowitz, Steven M ^a   Abbott, Geoffrey W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; CLARITHROMYCIN; FEXOFENADINE; ION CHANNEL; PROTEIN SUBUNIT;

ARRHYTHMOGENESIS; DISEASE PREDISPOSITION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GENE; GENE THERAPY; GENETIC VARIABILITY; HEART ARRHYTHMIA; HUMAN; ION CURRENT; LETHALITY; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES;

ANIMALS; ARRHYTHMIA; DEAFNESS; GENE THERAPY; HEART; HUMANS; ION CHANNELS; LONG QT SYNDROME; MUTATION; MYOCARDIUM; PHARMACOGENETICS;

EID: 0344737581     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.054569     Document Type: Review

References (40)

1. Abbott GW and Goldstein SA (2002) Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism. FASEB J 16:390-400.
2. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, and Goldstein SA (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187.
3. Abitbol I, Peretz A, Lerche C, Busch AE, and Attali B (1999) Stilbenes and fenamates rescue the loss of I(KS) channel function induced by an LQT5 mutation and other IsK mutants. EMBO (Eur Mol Biol Organ) J 18:4137-4148.
4. Berthet M, Denjoy I, Donger C, Demay L, Hammoude H, Klug D, Schulze-Bahr E, Richard P, Funke H, Schwartz K, et al. (1999) C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation 99:1464-1470.
5. Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, et al. (2003) A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 59:27-36.
6. Burton DY, Song C, Fishbein I, Hazelwood S, Li Q, DeFelice S, Connolly JM, Perlstein I, Coulter DA, and Levy RJ (2003) The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Hum Gene Ther 14:907-922.
7. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, et al. (1998) Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (Lond) 392:293-295.
8. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, et al. (2003) KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (Wash DC) 299:251-254.
9. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, and Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795-803.
10. Darwin CR (1859) On the Origin of Species, John Murray, London.
11. Finley MR, Li Y, Hua F, Lillich J, Mitchell KE, Ganta S, Gilmour RF Jr, and Freeman LC (2002) Expression and coassociation of ERG1, KCNQ1 and KCNE1 potassium channel proteins in horse heart. Am J Physiol Heart Circ Physiol 283:H126-H138.
12. Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, and Simonini S (2003) Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Electrophysiol 26:338-341.
13. Isbrandt D, Friederich P, Solth A, Haverkamp W, Ebneth A, Borggrefe M, Funke H, Sauter K, Breithardt G, Pongs O, et al. (2002) Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics. J Mol Med 80:524-532.
14. Kass RS and Cabo C (2000) Channel structure and drug-induced cardiac arrhythmias. Proc Natl Acad Sci USA 97:11683-11684.
15. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ, Hsu KL, Tseng CD, Lien WP, Tseng YZ, et al. (2002) Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 144:485-490.
16. Makkar RR, Fromm BS, Steinman RT, Meissner MD, and Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. (JAMA) J Am Med Assoc 270:2590-2597.
17. Mazhari R, Nuss HB, Armoundas AA, Winslow RL, and Marban E (2002) Ectopic expression of KCNE3 accelerates cardiac repolarization and abbreviates the QT interval. J Clin Investig 109:1083-1090.
18. McDonald TV, Yu Z, Ming Z, Palma E, Meyers MB, Wang KW, Goldstein SA, and Fishman GI (1997) A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature (Lond) 388:289-292.
19. Mendel G (1901) Versuche huber Pflanzenhybriden (1865-1869), W. Engelmann, Leipzig.
20. Mitcheson JS, Chen J, Lin M, Culberson C, and Sanguinetti MC (2000) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97:12329-12333.
21. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, et al. (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (Lond) 421:634-639.
22. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al. (1997) A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15:186-189.
23. Pietila E, Fodstad H, Niskasaari E, Laitinen PP, Swan H, Savolainen M, Kesaniemi YA, Kontula K, and Huikuri HV (2002) Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol 40:511-514.
24. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannoccone ST, Brunt E, Barohn R, et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Anderson's syndrome. Cell 105:511-519.
25. Priori SG, Napolitano C, and Schwartz PJ (1999) Low penetrance in the long-QT syndrome: clinical impact. Circulation 99:529-533.
26. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, and Danieli GA (2000) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholamine polymorphic ventricular tachycardia. Circulation 102: r49-r53.
27. Rajamani S, Anderson CL, Anson BD, and January CT (2002) Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation 105:2830-2835.
28. Roden D (2001) Pharmacogenetics and drug-induced arrhythmias. Cardiovascular Res 50:224-231.
29. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, and Keating MT (1996) Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (Lond) 384:80-83.
30. Sanguinetti MC, Jiang C, Curran ME, and Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299-307.
31. Schwartz PJ, Moss AJ, Vincent GM, and Crampton RS (1993) Diagnostic criteria for the long QT syndrome. Circulation 88:782-784.
32. Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, and Goldstein SA (2000) A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci USA 97:10613-10618.
33. Sesti F and Goldstein SA (1998) Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. J Gen Physiol 112:651-663.
34. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, and Keating MT (2000) Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1 and KCNE2. Circulation 102:1178-1185.
35. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, and Keating MT (2002) Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (Wash DC) 297:1333-1336.
36. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, and Keating MT (1997) Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 17:338-340.
37. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, et al. (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23.
38. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, and Keating MT (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80:805-811.
39. Windle JR, Geletka RC, Moss AJ, Zareba W, and Atkins DL (2001) Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol 6:153-158.
40. Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, et al. (2002) Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105:1943-1948.